Graft-versus-host disease - two scientific studies for better chances of cure after stem cell transplantation
Graft-versus-host disease (GvHD) – one of the most significant side effects of allogeneic hematopoietic stem cell transplantation (HSCT) – is still not entirely understood, nor can it be completely prevented, even after decades of research. Therefore, the DKMS Clinical Trials Unit (CTU) is conducting one retrospective study and one prospective study to find new successful approaches to minimize the disease burden.
An updated version of this page is available.